The future of genome editing in European healthcare systems

Gene-editing techniques are still relatively new, but are constantly multiplying, and they seem exciting in their promise, especially since a more precise version – CRISPR-Cas9 – has recently been used for the first time in a human trial. The use of CRISPR-Cas9 has generated a series of socio-ethical concerns about gene editing, which trigger societal debates and regulatory initiatives.

We discuss the potential impact of this technology regarded with attention but also concern both by public and scientists.

What if gene editing became routine practice?“, by Mihailis Kritikos, member of STOA.